Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / ALXO - ALX Oncology: Targeting The CD47 Receptor For Cancers

ALXO - ALX Oncology: Targeting The CD47 Receptor For Cancers

ALX Oncology Holdings Inc.
  • ALXO is a South Korea origin oncology concern valued at $3 billion on just phase 1 data.
  • They have just a single asset, a CD47 blocker with some special differences.
  • The molecule is interesting but may not be worth the valuation at this stage.

For further details see:

ALX Oncology: Targeting The CD47 Receptor For Cancers
Stock Information
Company Name: ALX Oncology Holdings Inc.
Stock Symbol: ALXO
Market: NASDAQ
Website: alxoncology.com
Menu
ALXO ALXO Quote ALXO Short ALXO News ALXO Articles ALXO Message Board
Get ALXO Alerts

News, Short Squeeze, Breakout and More Instantly...